Abstract:Alzheimer's disease (AD) has become a global threat to the elderly health with a short survival time after diagnosis. Due to the asymptomatic stage during the early development, patients are usually diagnosed at the middle or late stage. Therefore, an efficient tool for AD early diagnosis deserves considerable attention, which could make a significant contribution to the treatment intervention. A fluorescent probe has been widely applied for detecting and visualizing species of interest in vitro and in vivo, and the proper reaction between the probe and analytes is responsible for the fluorescence change to provide a lighting-on or ratiometric responsive pattern with satisfactory sensing behavior. In this work, we report the first attempt to build up an AND-logic probe P2 for AD accuracy diagnosis taking butyrylcholinesterase (BChE) and reactive oxygen species (ROSs) as dual targets. Upon the co-stimulation by these two factors through enzymatic hydrolysis and redox reaction, the NIR emission could be readily turned on. This AND sensing pattern avoided the false-positive response effectively, and other diseases sharing one biomarker could hardly induce a NIR fluorescence response. The sensing assay has also been confirmed to be feasible in vitro and in vivo with good sensibility and selectivity. It is worth mentioning that the probe structure has been optimized in terms of the linkage length. This study shows that probe P2 with a connecting arm of medium length (one methylene, n = 1) has superior sensing performance, promising to provide a reference for the relative structure design.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.analchem.1c02943.Experimental section, 1H, 13C NMR, and HR-MS spectral copies of synthesized compounds (Figures S1–S13), fluorescence, and HR-MS spectral profiles (Figures S14–S25), cell cytotoxicity of P1–P3 (Figure S26), spectra of P4 toward ROSs (Figure S27), and living cell imaging of probe P4 (Figure S28) and in vivo imaging (Figure S29) (PDF)This article has not yet been cited by other publications.

Developing a Two-Photon "AND" Logic Probe and Its Application in Alzheimer's Disease Differentiation

AND-Logic Strategy for Accurate Analysis of Alzheimer's Disease Via Fluorescent Probe Lighted Up by Two Specific Biomarkers.

AND-Logic Strategy for Accurate Analysis of Alzheimer’s Disease via Fluorescent Probe Lighted Up by Two Specific Biomarkers

Dual-Channel Imaging of Amyloid-β Plaques and Peroxynitrite to Illuminate Their Correlations in Alzheimer’s Disease Using a Unimolecular Two-Photon Fluorescent Probe

Diagnosis of Alzheimer's Disease and in Situ Biological Imaging Via an Activatable Near-Infrared Fluorescence Probe.

Current strategies for the development of fluorescence-based molecular probes for visualizing the enzymes and proteins associated with Alzheimer’s disease

Iterative Design of Near-Infrared Fluorescent Probes for Early Diagnosis of Alzheimer's Disease by Targeting Aβ Oligomers

Shedding Light on Alzheimer's Disease: Recent Advances in Highly Selective Fluorescent Probes

Development of Near-Infrared Fluorescent Probes for Use in Alzheimers Disease Diagnosis

An Activatable Near-Infrared Fluorescent Probe with Large Stokes Shift for Visualizing Peroxynitrite in Alzheimer’s Disease Models

Development of Near-Infrared Fluorescent Probes for Use in Alzheimer’s Disease Diagnosis

Targeting Β-Amyloid Plaques and Oligomers: Development of Near-Ir Fluorescence Imaging Probes.

Light-controlled Fluorescent Probes for Precisely Monitoring Brain Amyloid-Β Aggregates in Alzheimer's Disease

Research Progress Of Multi-Functional Fluorescent Probes For Alzheimer'S Disease Monitoring

Rational design synthesis and evaluation of a novel near-infrared fluorescent probe for selective imaging of amyloid-β aggregates in Alzheimer's disease

An activatable near-infrared fluorescent probe with large Stokes shift for visualizing peroxynitrite in Alzheimer's disease models

Advances of Molecular Imaging Probes for the Diagnosis of Alzheimer's Disease.

Design and synthesis of hemicyanine-based NIRF probe for detecting Aβ aggregates in Alzheimer's disease

Visualization of HOCl in the Brains of Alzheimer's Disease Models Using an Easily Available Two-Photon Fluorogenic Probe.

A Probe for NIR-II Imaging and Multimodal Analysis of Early Alzheimer’s Disease by Targeting CTGF

Simultaneous Sensing of H2S and ATP with a Two-Photon Fluorescent Probe in Alzheimer's Disease: toward Understanding Why H2S Regulates Glutamate-Induced ATP Dysregulation.